D.E. Shaw & Co’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$1.1M Sell
2024
Q4
$8.47M Buy
2024
Q3
$3.14M Buy
2023
Q1
Sell
2022
Q4
$9.88M Sell
2022
Q3
$12.9M Sell
2022
Q2
$8.78M Sell
2022
Q1
$14.5M Buy
2021
Q4
$15.1M Buy
2021
Q3
$11.9M Buy
2021
Q2
$13.2M Buy
2021
Q1
$3.15M Buy
2019
Q4
Sell
2019
Q3
$12K Sell
2019
Q2
$89K Sell
2019
Q1
$239K Buy
2018
Q4
$179K Buy